Occidental Asset Management LLC bought a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, Holdings Channel reports. The firm bought 12,644 shares of the company’s stock, valued at approximately $1,071,000.
A number of other large investors have also recently made changes to their positions in CTVA. Elevation Wealth Partners LLC raised its holdings in shares of Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the last quarter. Clearstead Trust LLC bought a new stake in Corteva in the 2nd quarter worth approximately $31,000. JPL Wealth Management LLC bought a new stake in Corteva in the 3rd quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new stake in Corteva during the 2nd quarter valued at $33,000. Finally, Westfuller Advisors LLC raised its stake in Corteva by 2,764.3% during the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after buying an additional 387 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CTVA has been the topic of a number of research reports. UBS Group raised their price target on Corteva from $86.00 to $89.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Royal Bank Of Canada increased their target price on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday, July 21st. JPMorgan Chase & Co. raised their target price on Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $91.70.
Corteva Price Performance
Shares of Corteva stock opened at $75.73 on Tuesday. The stock has a market cap of $50.53 billion, a P/E ratio of 50.15, a P/E/G ratio of 2.35 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The stock’s fifty day moving average is $81.78 and its 200 day moving average is $80.09. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97.
Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s payout ratio is 47.68%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
